About Dexcel Pharma
Dexcel Pharma is a company based in Or Akiva (Israel). It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Dexcel Pharma offers products and services including Branded Rx, OTC Products, and Generics.
- Headquarter Or Akiva, Israel
- SectorsHealthcare
- Phone•••• ••••
- Website dexcel.com
Products & Services of Dexcel Pharma
Dexcel Pharma offers a comprehensive portfolio of products and services, including Branded Rx, OTC Products, and Generics.
Innovative drugs are offered across various therapeutic areas.
National brands and private-label pharmaceuticals are provided.
Broad portfolio of niche generics is commercialized globally.
People of Dexcel Pharma
56 people are tracked at Dexcel Pharma (20 in leadership, 36 in team).
| Name | Role | Group |
|---|---|---|
Osnat Penn | Head Of Bioinformatics, RNA Therapeutics | Leadership |
Neil Cook | Head Of Sales & Portfolio Management | Leadership |
Amit Bar - On | Director Of Financial Planning And Analysis | Leadership |
Yaron Erez | Vp, Chief Financial Officer | Leadership |
Dan Oren | Founder & | Leadership |
Uri Oren | Co-chief | Leadership |
Dafna Arieli | Head Of Product Scientific Support Unit At Dexcel Pharma | Leadership |
Amit Rotem | VP Human Resources | Leadership |
Dave Preston | Head Of Quality | Leadership |
Mekonnen Gemechu | Head Quality Control | Leadership |
Ran Kreshtino | Vice President & General Manager Dexcel Pharma Israel | Leadership |
Ygal Seelenfreund | Vice President International Sales & Marketing | Leadership |
Iris Givon | Director Of Sales & Marketing - Pharma (promoted Products), | Leadership |
Andrew Ridsdale | Managing Director | Leadership |
Ziv Teresh | Vp, Chief Operating Officer | Leadership |
Jonathan Grushka | Vp, General Counsel | Leadership |
Eyal Dayan | Vp, Research & Development | Leadership |
Shay Sela | Head Of RNA Therapeutics | Leadership |
Craig Millard | Director Of Finance, HR & Supply Chain | Leadership |
Tamar Galanty | Vp, Head Of Quality | Leadership |
36 more people are available in the full profile.
Complete people profiles for Dexcel Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Dexcel Pharma
Websites that share an audience with Dexcel Pharma (dexcel.com).
Websites whose visitors overlap most with Dexcel Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cordenpharma.com | 81% | 26.2K | #789,402 | View details | |
| holmesplace.co.il | 43% | 179.2K | #257,959 | View details |
Similar companies to Dexcel Pharma
10 companies that operate in the same segment as Dexcel Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dexcel Pharma
Dexcel Pharma is headquartered in Or Akiva, Israel. It is registered at Or Akiva, Central District, Israel.
Dexcel Pharma is involved in the development, manufacturing, and commercialization of innovative and generic pharmaceutical products worldwide. Operations are focused on branded prescription drugs, over-the-counter products, and a broad portfolio of generics across various dosage forms. The company is committed to research and development in small molecules, biologics, oligonucleotides, and genetic medicine. Key markets include the United States, Israel, Germany, the United Kingdom, and Austria, supported by a global network of affiliates and distributors.
Dexcel Pharma offers Branded Rx, OTC Products, and Generics.